Skip to content
10-Q

Quarterly Report

Nuo Therapeutics, Inc. AURX

0001437749-25-024043

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 29, 2025 46.83M sh
Capex Q2 2025 · Jun 30, 2025 $231.55K
Capex Q2 2025 · Jun 30, 2024 $4.1K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $264.19K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.25M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $316.35K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $283.71K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$824.56K
Stockholders Equity Q2 2025 · Mar 31, 2025 −$213.07K
Stockholders Equity Q2 2025 · Dec 31, 2024 $513.71K
Stockholders Equity Q2 2025 · Jun 30, 2024 $598.51K
Stockholders Equity Q2 2025 · Mar 31, 2024 $333.45K
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.04M
Current Liabilities Q2 2025 · Jun 30, 2025 $998.96K
Current Liabilities Q2 2025 · Dec 31, 2024 $578.45K
Total Liabilities Q2 2025 · Jun 30, 2025 $2.18M
Total Liabilities Q2 2025 · Dec 31, 2024 $675.8K
Current Assets Q2 2025 · Jun 30, 2025 $853.28K
Current Assets Q2 2025 · Dec 31, 2024 $841.55K
Total Assets Q2 2025 · Jun 30, 2025 $1.36M
Total Assets Q2 2025 · Dec 31, 2024 $1.19M
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.03
Sga Expense Q2 2025 · Jun 30, 2025 $1.19M
Sga Expense Q2 2025 · Jun 30, 2025 $2.3M
Sga Expense Q2 2025 · Jun 30, 2024 $841.42K
Sga Expense Q2 2025 · Jun 30, 2024 $1.73M
Net Income Q2 2025 · Jun 30, 2025 −$649.69K
Net Income Q2 2025 · Jun 30, 2025 −$1.4M
Net Income Q2 2025 · Mar 31, 2025 −$746.13K
Net Income Q2 2025 · Jun 30, 2024 −$540.09K
Net Income Q2 2025 · Jun 30, 2024 −$1.25M
Net Income Q2 2025 · Mar 31, 2024 −$708.78K
Operating Income Q2 2025 · Jun 30, 2025 −$652.02K
Operating Income Q2 2025 · Jun 30, 2025 −$1.4M
Operating Income Q2 2025 · Jun 30, 2024 −$541.98K
Operating Income Q2 2025 · Jun 30, 2024 −$1.25M
Gross Profit Q2 2025 · Jun 30, 2025 $540.85K
Gross Profit Q2 2025 · Jun 30, 2025 $904.21K
Gross Profit Q2 2025 · Jun 30, 2024 $299.44K
Gross Profit Q2 2025 · Jun 30, 2024 $483.42K